MENU
doctors looking at a tablet

Integrated Care Pathways

Home/Our Consensus Services/Integrated Care Pathways

Evidence-based treatment recommendations only improve patient outcomes when they are implemented consistently in clinical practice. Triducive develops Integrated Care Pathways (ICPs) that translate expert consensus, clinical evidence and multidisciplinary best practice into practical, implementable models of care.

Whether delivered as a standalone project or alongside a Delphi consensus programme, our Integrated Care Pathways help healthcare professionals implement best practice, reduce unwarranted variation in care, and improve patient outcomes across the healthcare journey.

100+ care pathways developed and implemented across multiple therapeutic areas, including rare diseases.

What is an Integrated Care Pathway?

An Integrated Care Pathway is a structured, evidence-based framework that supports the organisation and delivery of care for a defined patient population over a defined period.

According to the European Pathway Association, care pathways are designed to:

  • Define clear goals and evidence-based standards of care
  • Improve communication between multidisciplinary teams, patients and caregivers
  • Coordinate roles and sequencing of care across services
  • Document, monitor and evaluate outcomes
  • Optimise the use of healthcare resources

The ultimate objective is to improve quality of care, enhance patient safety, increase patient satisfaction and deliver better health outcomes while making more efficient use of resources.

Correct Application of Delphi method

Our approach

We work with healthcare professionals to create pathways that are practical, implementable and capable of driving real-world change.

Our experience includes:

  • Development and implementation of over 100 Integrated Care Pathways
  • Extensive work across common conditions and complex rare diseases
  • Engagement of multidisciplinary clinical teams
  • Translation of Delphi consensus into clinical practice
  • Development of costed pathways to support market access discussions
  • Training programmes, implementation materials and stakeholder briefings
  • Support for peer-reviewed publications and congress presentations

Why organisations invest in Integrated Care Pathways

Improve consistency of care. Reduce unwarranted variation by translating evidence and expert consensus into clear clinical pathways.

Strengthen multidisciplinary collaboration. Create alignment between specialists, nurses, allied healthcare professionals and primary care teams through shared care planning.

Improve patient experience. Help patients understand their care journey, expected milestones and treatment goals through a transparent, coordinated approach.

Support education and implementation. Integrated Care Pathways provide valuable educational resources for new clinicians while reinforcing best practice across experienced teams.

Generate real-world insights. Standardised pathways facilitate audit, outcome measurement and continuous quality improvement.

Inform market access. Costed care pathways provide valuable evidence to support health economic discussions and demonstrate the resource implications of new therapies.

Related Case Studies

Sickle Cell Disease

Sickle Cell Disease presents one of the most complex care journeys in modern healthcare.

Patients require coordinated input from specialists in haemoglobinopathies alongside emergency medicine, pain management, nephrology, ophthalmology, respiratory medicine, stroke services, endocrinology and other disciplines. As treatment options evolve, variation in care can increase, particularly during the transition from paediatric to adult services.

Triducive worked with clinical experts to develop an Integrated Care Pathway that:

  • Standardised multidisciplinary care
  • Reduced unwarranted variation in treatment
  • Improved coordination across specialist services
  • Supported transition between paediatric and adult care
  • Created a framework capable of incorporating emerging therapies

The pathway provided a practical model that clinicians could implement while supporting ongoing service improvement.

Clostridioides difficile infection

Implementation of Integrated Care Pathways has delivered measurable value for healthcare organisations.

Following rollout of an Integrated Care Pathway programme across six Austrian centres for Clostridioides difficile infection, participating institutions reported:

  • Adoption of the pathway into routine clinical practice
  • Integration into undergraduate medical education
  • Improved measurement of treatment outcomes
  • Greater consistency in prescribing decisions
  • Use as a training resource for new clinicians
  • Strong support from antimicrobial stewardship leaders

Integrated Care Pathways as part of a Delphi programme

Many pharmaceutical teams choose to develop an Integrated Care Pathway following a Delphi consensus study.

This approach enables expert agreement to be translated into an actionable clinical framework that can be implemented in practice, extending the value of the consensus process beyond publication and supporting meaningful improvements in patient care.

Why Triducive?

Our combination of scientific expertise, facilitation skills and implementation experience enables us to deliver pathways that are both clinically robust and practically usable.

With more than 100 pathways developed and implemented, we help organisations move from expert consensus to measurable improvements in healthcare delivery.

integrated evidence planning

A Guide to Using Consensus Methods in Integrated Evidence Planning

13th August 2025

A Practical Guide to Using Consensus Methods in Integrated Evidence Planning   Consensus methods provide Medical Affairs teams with a practical, scientifically rigorous approach to bridging evidence gaps that clinical trials and real-world studies alone may not fully address. By systematically capturing and synthesizing expert insights, these methods can help establish best practices, shape treatment…

Real world evidence

Real World Evidence – And Other Ways of Changing Healthcare

9th June 2025

Real World Evidence – And Other Ways of Changing Healthcare   As the healthcare landscape grows more complex and data-driven, so too must the methods used to generate evidence. Traditionally, randomized controlled trials (RCTs) have been held as the gold standard, valued for minimizing bias and demonstrating causality. However, their design is based on highly…

consensus company

How to Select a Consensus Company to Support Your Evidence Plan

7th May 2024

How to Select a Consensus Company to Support Your Evidence Plan   Expert consensus is playing an increasingly vital role in today’s healthcare decision-making. It can often be used to inform clinical guidance, support regulatory submissions, address variations in care, or align healthcare stakeholders behind a common vision. As organisations across pharma, life sciences, and…

Book a meeting with us

SCHEDULE MEETING

FAQs

What is an Integrated Care Pathway?

A structured, evidence-based framework that supports the organisation and delivery of care for a defined patient population over a defined period – translating expert consensus, clinical evidence and multidisciplinary best practice into a practical, implementable model of care.

What are the benefits of an Integrated Care Pathway?

Care pathways improve consistency of care, strengthen multidisciplinary collaboration, improve patient experience, support education and implementation, generate real-world insights through audit and outcome measurement, and inform market access through costed pathways.

How does an Integrated Care Pathway relate to a Delphi consensus study?

They can be delivered standalone or together. A Delphi panel establishes measured expert consensus on best practice; an Integrated Care Pathway translates that consensus into an actionable clinical framework, extending the value of the consensus beyond publication.

What experience does Triducive have developing care pathways?

Triducive has developed and implemented more than 100 Integrated Care Pathways across multiple therapeutic areas – from common conditions to complex rare diseases, including costed pathways that support market access discussions.

Testimonials

“This will hopefully transform patient care in the UK”
Consultant Respiratory Physician, UK
“I would like to express my deep gratitute for your team’s wonderful achievements”
Professor in Cardiovascular Immunology, South Korea
“They understand the scope of the work and what we are trying to achieve with what we're doing”
Professor of Pulmonary Medicine, Canada
“In my experience, you have done the most outstanding work”
Project Manager, Global Healthcare Company, Japan
“There is now so much weight of opinion that payers don’t have any reason to say 'no'”
Brand Director, Global Pharma Company, EU
“This will add to the evidence base that will inform future practice across the the EU”
Cardiothoracic Surgeon, Italy
“A great support to transform future surgery across the EU”
Chair, ETST
“This now provides clear focus in an area that has been confused for a long time”
Microbiologist, Germany
“We remember how unusually excellent you were in this project”
Global Medical Affairs Director, Global Pharma Company, UK
“A great piece of work”
Patient Organisation Leader
“They’ve managed to facilitate a publication in a really high impact journal that's gonna make a difference to the management of patients, not just for clinicians like me in the UK but also around the world”  
Professor of Renal Medicine, UK
“What a fantastic job you have all done”
Haematologist, UK

Sign up to our Newsletter